Japan Apheresis Market Poised for Robust Growth Driven by Rising Demand for Devices, Therapeutic Innovations, and Advanced Blood Separation Technologies

Leander, Texas and TOKYO, Japan - Dec. 9. 2025 "Japan apheresis Market is anticipated to grow at high CAGR during the forecast period 2024-2031."

The Japan Apheresis Market is driven by rising demand for advanced blood component separation techniques used in treating autoimmune disorders, hematological diseases, and metabolic conditions. Market growth is supported by expanding adoption of therapeutic apheresis, technological advancements in apheresis devices, and increasing utilization in hospitals and blood centers to ensure safe and efficient blood management.

➠ Download Your Sample Report Instantly - Corporate Email ID Required for Priority Access: https://www.datamintelligence.com/download-sample/japan-apheresis-market?praneetha

☛ Japan Recent Industry Developments :
✅ December 2025 :
Terumo Corporation launched its latest automated plasma apheresis system designed for improved efficiency in hematology and immunology treatments. The company invested ¥7.8 billion to upgrade manufacturing capabilities and expand clinical adoption across major Japanese hospitals.

✅ November 2025 :
Kawasumi Laboratories completed the acquisition of a domestic biomedical equipment supplier to strengthen its apheresis device portfolio. The deal was supported by a ¥4.3 billion investment aimed at integrating advanced filtration technologies for therapeutic plasma exchange.

✅ October 2025 :
Asahi Kasei Medical introduced next generation leukocyte and platelet apheresis filters for oncology and autoimmune disease management. The company committed ¥5.1 billion toward R&D enhancements and regulatory approvals to accelerate nationwide deployment.

☛ Core Catalysts Behind Market Growth :
Escalating chronic disease burdens and regulatory guidelines from Japan Society for Apheresis are accelerating adoption of therapeutic procedures like plasmapheresis for improved clinical efficacy and compliance.

Government subsidies under national health plans, coupled with R&D collaborations via AMED, are fueling innovations in centrifugation and filtration technologies to address blood shortages and enhance donor processes.

Growing demand in hospitals and blood banks for precise, automated apheresis solutions is driving market penetration and scalability in urban healthcare hubs.

Technological advancements in disposable consumables, AI-driven monitoring, and extracorporeal therapies are improving safety, reducing infection risks by up to 40%, and enabling broader applications in neurology and oncology.

➠ Get Customization in the Report as per Your Requirements: https://www.datamintelligence.com/customize/japan-apheresis-market?praneetha

☛ Market Segmentation :
By Type :
Devices lead with 58% share, driven by strong adoption of advanced automated apheresis systems across hospitals and blood banks. Consumables & accessories hold the remaining 42% share, supported by recurring demand for disposable kits, filters, and tubing sets required for every procedure, ensuring continuous revenue growth.

By Technology :
Centrifugation dominates with 67% share, owing to its high accuracy in separating blood components and its use in most donor and therapeutic procedures in Japan. Membrane filtration accounts for 33% share, expanding steadily as a gentler, biocompatible method preferred in chronic treatment cycles and advanced therapeutic care.

By Procedure :
Plasmapheresis leads with 38% share, widely used in plasma donation and therapeutic treatments for autoimmune and neurological disorders. Plateletpheresis holds 22% share, driven by strong clinical demand for platelet concentrates in oncology and surgery. Erythrocytapheresis accounts for 14% share, utilized for red blood cell removal in conditions such as sickle cell disease. Leukapheresis holds 16% share, essential for leukemia management and cell-therapy preparation. Other procedures represent the remaining 10% share, including photopheresis, lipid apheresis, and stem cell collection.

By Application :
Donor blood apheresis leads with 62% share, supported by structured national donation programs and demand for plasma, platelets, and RBC components. Therapeutic apheresis accounts for 38% share, driven by rising cases of autoimmune, metabolic, and neurological diseases requiring periodic and specialized treatments.

By End Users :
Hospitals dominate with 54% share, offering comprehensive therapeutic apheresis services across emergency, chronic, and specialty care. Blood banks hold 28% share, driven by large-scale donor apheresis operations. Clinics account for 12% share, providing selective long term management treatments. Other end users represent 6% share, including research centers and specialized treatment facilities expanding apheresis applications.

☛ Competitive Landscape :
The market is moderately consolidated with domestic leaders and global players focusing on training initiatives and membrane innovations for therapeutic dominance.

Asahi Kasei Medical Co., Ltd. - Commands an estimated 25% share, excelling in membrane filtration systems like Planova for plasma therapies, strengthened by educational programs and R&D expansions.

Terumo Corporation - Holds about 20% market share, renowned for Spectra Optia centrifuges in donor apheresis, bolstered by acquisitions and training launches for cell collection.

Haemonetics Corporation - Captures around 18% of the market, providing comprehensive devices and consumables with a focus on automation for hospitals via MHLW backed integrations.

KANEKA CORPORATION - Maintains approximately 12% share through specialized filters for leukapheresis, emphasizing preeclampsia and autoimmune applications.

B. Braun SE - Secures roughly 10% market share via durable apheresis machines, with growing presence in clinics through partnerships.

Other Key Players: SB-KAWASUMI LABORATORIES, INC., Otsuka Medical Devices Co., Ltd., Nikkiso Co., Ltd., TAGCyx Biotechnologies.

➠ Purchase this report before year-end and unlock an exclusive 30% discount :

Buy Now & Unlock 360° Market Intelligence : https://www.datamintelligence.com/buy-now-page?report=japan-apheresis-market?praneetha
(Purchase 2 or more Reports and get 50% Discount)

☛ Regional Analysis :
Akita :
Akita holds 8%, driven by a growing elderly population and increasing adoption of therapeutic apheresis procedures in regional hospitals. Investment in modern blood collection and transfusion infrastructure supports steady growth.

Aomori :
Aomori accounts for 7%, supported by rising utilization of apheresis in treating autoimmune and hematological disorders. Improved access to specialized healthcare facilities strengthens market expansion.

Chiba :
Chiba holds 15%, due to its proximity to Tokyo, advanced medical infrastructure, and high patient volume. Major hospitals and blood centers widely adopt apheresis technology for platelet, plasma, and leukocyte collection.

Fukui :
Fukui represents 6%, driven by increasing awareness of advanced blood separation procedures and ongoing upgrades in hospital capabilities. Adoption is concentrated in key public and private medical centers.

Fukuoka :
Fukuoka accounts for 12%, supported by well developed healthcare systems, rising demand for therapeutic apheresis, and the presence of specialized clinics and large hospitals serving Kyushu.

Others (Tokyo, Osaka, Kanagawa, Saitama, Hokkaido, etc.)
The "Others" category holds 52%, driven by high patient density, advanced hospital networks, and the presence of national blood centers. Tokyo, Osaka, and Kanagawa dominate due to superior healthcare infrastructure, broad adoption of apheresis equipment, and significant investment in medical technology.

➠ Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Market Access Snapshots
✅ Emerging Risks & Market Volatility Analysis
✅ Quarterly Updated Reports
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Company Name: DataM Intelligence 4Market Research LLP
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com/

DataM Intelligence is a global Market Research and Consulting firm providing comprehensive business insights and end-to-end solutions from research to consulting. We deliver actionable intelligence across 6,300+ reports spanning 40+ domains, empowering over 200 companies in 50+ countries. Our focus is on enabling clients to make data-driven decisions through robust methodologies, strategic foresight, and real-time market intelligence.

This release was published on openPR.